Literature DB >> 21945006

Molecular network of microRNA targets in Alzheimer's disease brains.

Jun-ichi Satoh1.   

Abstract

MicroRNAs (miRNAs) are a group of small noncoding RNAs that regulate translational repression of target mRNAs. The vast majority of presently identified miRNAs are expressed in the brain where they fine-tune the expression of a wide range of target molecules essential for neuronal and glial development, differentiation, proliferation, apoptosis and metabolism. Aberrant expression and dysfunction of brain-enriched miRNAs induce development of neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD). Because a single miRNA concurrently downregulates hundreds of target mRNAs, the set of miRNA target genes coregulated by an individual miRNA generally constitutes the biologically integrated network of functionally associated molecules. Recent advances in systems biology enable us to characterize the global molecular network of experimentally validated targets for individual miRNAs by using pathway analysis tools of bioinformatics endowed with comprehensive knowledgebase. This review is conducted to summarize accumulating studies focused on aberrant miRNA expression in AD brains, and to propose the systems biological view that abnormal regulation of cell cycle progression as a result of deregulation of miRNA target networks plays a central role in the pathogenesis of AD.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945006     DOI: 10.1016/j.expneurol.2011.09.003

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  35 in total

1.  MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.

Authors:  Sabrina Absalon; Dawn M Kochanek; Venkatesan Raghavan; Anna M Krichevsky
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 2.  Pathway analysis of the human brain transcriptome in disease.

Authors:  Tomas Kavanagh; James D Mills; Woojin S Kim; Glenda M Halliday; Michael Janitz
Journal:  J Mol Neurosci       Date:  2012-12-22       Impact factor: 3.444

Review 3.  Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review.

Authors:  Peter Csermely; Tamás Korcsmáros; Huba J M Kiss; Gábor London; Ruth Nussinov
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

4.  Identification of microRNAs involved in Alzheimer's progression using a rabbit model of the disease.

Authors:  Qing Yan Liu; Marilyn N Vera Chang; Joy X Lei; Roger Koukiekolo; Brandon Smith; Dongling Zhang; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2014-03-28

5.  Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model.

Authors:  Nupur Dasgupta; You-Hai Xu; Ronghua Li; Yanyan Peng; Manoj K Pandey; Stuart L Tinch; Benjamin Liou; Venette Inskeep; Wujuan Zhang; Kenneth D R Setchell; Mehdi Keddache; Gregory A Grabowski; Ying Sun
Journal:  Hum Mol Genet       Date:  2015-09-29       Impact factor: 6.150

6.  MicroRNA-98 induces an Alzheimer's disease-like disturbance by targeting insulin-like growth factor 1.

Authors:  Yi-Kui Hu; Xun Wang; Lian Li; Yan-Hua Du; Heng-Tai Ye; Cheng-Yan Li
Journal:  Neurosci Bull       Date:  2013-06-05       Impact factor: 5.203

7.  Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.

Authors:  Jian Zhang; Mei Hu; Zhaoqian Teng; Ya-Ping Tang; Chu Chen
Journal:  J Neurosci       Date:  2014-11-05       Impact factor: 6.167

8.  Pathway analysis from lists of microRNAs: common pitfalls and alternative strategy.

Authors:  Patrice Godard; Jonathan van Eyll
Journal:  Nucleic Acids Res       Date:  2015-03-23       Impact factor: 16.971

9.  Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration.

Authors:  Minati Singh
Journal:  Front Genet       Date:  2013-01-22       Impact factor: 4.599

10.  Environmental contaminants and microRNA regulation: Transcription factors as regulators of toxicant-altered microRNA expression.

Authors:  James Sollome; Elizabeth Martin; Praveen Sethupathy; Rebecca C Fry
Journal:  Toxicol Appl Pharmacol       Date:  2016-06-10       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.